Nevro Corp (NVRO) PT Lowered to $142 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst David Turkaly lowered the price target on Nevro Corp (NYSE: NVRO) to $142.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
